MNKD is a long term hold, period.

Buffett bought/buys companies with solid prospects and good fundamentals when he could get them at a good price (on technical price pullbacks).

MNKD has solid prospects and it's at a good price. Fundamentals suck though, and that's the issue.

Warren won't be buying MNKD.

I'll be holding MNKD for a long while. And the reason I'll be holding for a long time - there exists in this country (and worldwide) a "bunch" of overweight and obese people, and this bunch is growing numerically, and will continue to do so into the foreseeable future. That equates to an increasing number of diabetics. And MNKD has a great solution to help them. MNKD's solution also addresses the type I population. I have firsthand experience witnessing the devastation that diabetes wreaks, it's terrible. The FDA made a huge, huge mistake by not letting this drug come to market in Jan 2011 - it has cost lives, it has cost debilitation.

So there you have it in a nutshell:

Type 1 diabetics + an ever-increasing population of type 2 diabetics related to the obesity epidemic = Big Problem.

MNKD's Afrezza, a novel, life-changing elegant solution.

Just buy the stock, ignore the noise (they'll get funding, and it'll get thru the FDA), and hold it.

I said in a prvious post that upside to this stock was $12.50 - that was a typo, I meant $112.50. Whew, I feel better now, don't you?